ArticlePlastic and reconstructive surgery. Global open2026
Collagenase Versus Operative Management for Dupuytren Contracture: A Propensity-matched Cohort of 16,888 Patients.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dupuytren contracture (DC) is a fibroproliferative disorder of the palmar fascia, commonly managed through enzymatic collagenase injections or surgical interventions such as fasciotomy or fasciectomy. This study aims to compare clinical outcomes and complication rates between patients undergoing collagenase injection and those receiving surgical treatment for DC. Methods: Using the TriNetX US Collaborative Network, a retrospective cohort study was conducted including 8444 patients who underwent collagenase injection and 8444 propensity score-matched patients who received surgical management for DC. Key outcomes assessed included postoperative infection, hematoma, nerve injury, reintervention rates, functional outcomes (occupational therapy utilization), and emergency room visits. Risk differences, risk ratios, and odds ratios (OR) were calculated using risk analysis. Follow-up was 180 days. Results: Collagenase treatment was associated with significantly lower risks of postoperative infection (0.7% versus 1.4%, OR 0.49, Conclusions: Collagenase injection for DC is associated with fewer short-term complications but nearly doubles the risk of reintervention compared to surgical management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.